Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2077558 | 0.72 | — | — | |
| SCHEMBL2081042 | 0.72 | — | — | |
| SCHEMBL2078747 | 0.72 | — | — | |
| SCHEMBL12086408 | 0.69 | CYP1A2 (0.42) | CHRM4CHRM5CHRM1CHRM3CYP1A2 | |
| SCHEMBL13954390 | 0.69 | POLB (0.33) | CHRM4CHRM5CHRM1CYP2C9CHRM3 | |
| SCHEMBL11099301 | 0.69 | — | — | |
| SCHEMBL1092390 | 0.67 | — | — | |
| SCHEMBL2079084 | 0.67 | — | — | |
| SCHEMBL5573177 | 0.67 | — | — | |
| SCHEMBL13932363 | 0.67 | CHRM5 (0.36) | CHRM4CHRM5CHRM1CHRM3CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296918-A1 | METHOD FOR PRODUCING MERCAPTO HETEROCYCLIC COMPOUND AND METHOD FOR TESTING THE SAME | RESONAC CORPORATION (JP) | 2025-09-25 | — | — | US | disclosed |
| WO-2023210608-A1 | PRODUCTION METHOD AND TEST METHOD FOR MERCAPTO HETEROCYCLIC COMPOUND | 株式会社レゾナック | 2023-11-02 | — | — | WO | disclosed |
| WO-2015198923-A1 | COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2015-12-30 | — | — | WO | disclosed |
| US-8961946-B2 | Hair processing agent and method for permanent waving hair | SHOWA DENKO K.K. (JP) | 2015-02-24 | — | — | US | disclosed |
| EP-2024330-B1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | SHOWA DENKO KK (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-7902383-B2 | Production method of heterocyclic mercapto compound | SHOWA DENKO K.K. (JP) | 2011-03-08 | — | — | US | disclosed |
| EP-1896139-B1 | PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT | SHOWA DENKO KK (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-20090171095-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | SHOWA DENKO K.K. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090081147-A1 | PERMANENT WAVING AGENT | SHOWA DENKO K.K. (JP) | 2009-03-26 | — | — | US | disclosed |
| EP-2024330-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | Showa Denko K.K. (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-20080131389-A1 | Hair Relaxer | SHOWA DENKO K.K. (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | RESONAC CORPORATION (JP) | 2008-04-10 | — | — | US | disclosed |
| EP-1896139-A2 | PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT | Showa Denko K.K. (JP) | 2008-03-12 | — | — | EP | disclosed |
| WO-2007139215-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | SHOWA DENKO K.K. (JP) | 2007-12-06 | — | — | WO | disclosed |
| EP-1845940-A1 | HAIR RELAXER | Showa Denko K.K. (JP) | 2007-10-24 | — | — | EP | disclosed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006121214-A2 | PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT | SHOWA DENKO K.K. (JP) | 2006-11-16 | — | — | WO | disclosed |
| WO-2006083031-A1 | HAIR RELAXER | SHOWA DENKO K.K. (JP) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080131389-A1 | Hair Relaxer | BHMT2, BHMT, MGMT | CHRM4 249/4885CHRM5 813/4885CHRM1 968/4885 |
| US-20250296918-A1 | METHOD FOR PRODUCING MERCAPTO HETEROCYCLIC COMPOUND AND METHOD FOR TESTING THE SAME | MPST, TST, DHPS | CHRM4 1389/4885CHRM5 1119/4885CHRM1 2171/4885 |
| US-20090081147-A1 | PERMANENT WAVING AGENT | SULT2A1, SULT1A1, CYP2F1 | CHRM4 1810/4885CHRM5 1903/4885CHRM1 905/4885 |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | TST, CYSLTR1, CYSLTR2 | CHRM4 674/4885CHRM5 597/4885CHRM1 204/4885 |
| US-20090171095-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | POR, SULT2A1, CYP2E1 | CHRM4 129/4885CHRM5 90/4885CHRM1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.